Ozempic and Wegovy drugmaker CEO defends high costs of drugs

IE 11 is not supported. For an optimal experience visit our site on another browser.

  • Now Playing

    Ozempic and Wegovy drugmaker CEO defends high costs of drugs

    02:44

  • UP NEXT

    Missouri’s attorney general has a history of opposing efforts to overturn prison convictions

    02:49

  • FBI crime report says violent crime saw a 3% drop in 2023

    02:15

  • Israel declares special state of emergency as Hezbollah returns rocket fire

    03:28

  • Suspect in apparent Trump assassination attempt to remain in jail until trial

    02:56

  • Soldier Travis King, who ran into North Korea, pleads guilty to desertion

    02:06

  • Georgia election board orders votes to be counted by hand

    02:44

  • Deaf marathoner set to make history by running in six major races

    04:10

  • Michigan deputy dives through window to stop out-of-control car

    02:19

  • Lebanon doctors describe injuries from device blasts

    04:22

  • ‘More work to do’: Biden praises economic progress following Fed rate cuts

    01:50

  • Kentucky couple find body believed to be highway shooting suspect

    02:55

  • This marriage-focused platform plays matchmaker for South-Asian Americans

    03:53

  • Federal reserve cuts interest rates by 0.5%

    04:17

  • New reports of explosions in Lebanon one day after pager attacks

    02:52

  • Hezbollah says handheld devices exploded causing injuries across Lebanon

    02:47

  • Ghana’s issues with illegal mining reflect broader challenges with the gold industry

    02:02

  • Ellison Barber describes her interactions with Trump suspect while stationed in Ukraine

    01:22

  • Former New York fire chiefs accused of bribery scheme

    03:25

  • Bodycam footage released of officers arresting suspect in Trump assassination attempt

    03:29

Novo Nordisk chief executive Lars Fruergaard Jørgensen faced questioning on Capitol Hill over the health care costs of the company’s weight-loss drugs Ozempic and Wegovy. NBC News’ Christine Romans reports on how Jørgensen claimed the high prices were due to complications of the U.S. healthcare system.

Source link